Table 3.
Type | Inheritance | Gene/locus | Specific phenotype |
HSAN I (HSN1) | AD | SPTLC1 | Mainly sensory, sensory complications, motor involvement variable, neuropathic pain |
CMT2B | AD | RAB7 | Sensorimotor, sensory complications, no pain |
HSAN 1B | AD | 3p22-p24 | Sensory, cough, gastroesophageal reflux |
HSAN II | AR | HSN2 | Severe sensory complications, mutilations, onset first two decades |
HSAN III | AR | IKBKAP | Familial dysautonomia or Riley-Day syndrome, prominent autonomic, absence fungiform papillae of the tongue |
HSAN IV | AR | NTRK1 | Congenital insensitivity to pain with anhydrosis (CIPA), severe sensory, anhydrosis, mental retardation, unmyelintated fibers mainly affected |
HSAN V | AR | NTRK1 | Congenital insensitivity to pain with mild anhydrosis, no mental retardation, small myelinated fibers mainly affected |
HSAN V | AR | NGFB | Congenital insensitivity to pain, minimal autonomic, no mental retardation, mainly unmyelinated fibers affected |
Channelopathy | AR | SCN9A | Congenital insensitivity to pain. Associated insensitivity to pain |
SPLTC1 = serine palmitoyltransferase, long-chain base subunit-1; HSN2 = hereditary sensory neuropathy type II gene; IKBKAP = inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase complex-associated protein; NTRK1 = neurotrophic tyrosine kinase receptor type 1; NGFB = nerve growth factor beta polypeptide; SCN9A = sodium channel, voltagegated, type IX, alpha subunit